Ultrasound-Assisted Cerium-Doped Zeolite Nanocomplex Attenuates Adenomyosis via Wnt/β-Catenin Pathway Inhibition and IGFBP5 Downregulation in SFRP4⁺ NKT Cells
Lab / animal
OA: gold
CC0
AI-generated summary
Ultrasound-assisted synthesized cerium-doped zeolite nanocomplexes attenuated adenomyosis by inhibiting the Wnt/β-catenin pathway and downregulating IGFBP5 in SFRP4⁺ NKT cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Adenomyosis is a chronic gynecological disorder characterized by ectopic endometrial tissue within the myometrium, leading to pelvic pain, menorrhagia, and infertility. Increasing evidence implicates dysregulated Wnt/β-catenin signaling and aberrant activation of SFRP4+ natural killer T (NKT) cells in disease progression. This study reports the ultrasound-assisted synthesis of a cerium-doped zeolite nanocomplex (Ce-ZNC) and evaluates its therapeutic efficacy in experimental models of adenomyosis. Ce-ZNC was synthesized via an ultrasound-assisted doping approach and characterized using transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), dynamic light scattering (DLS), and polydispersity index (PDI) analysis. In vitro studies were conducted on human peripheral blood mononuclear cell (PBMC)-derived SFRP4⁺ NKT cells. In vivo efficacy was evaluated in a murine adenomyosis model. IGFBP5 expression and Wnt/β catenin signaling components were analyzed by RT-qPCR and Western blotting. Histological and cytokine analyses were performed to assess fibrosis and inflammation. Ce-ZNC exhibited spherical morphology with nanoscale dimensions and good colloidal stability. Treatment resulted in a dose-dependent suppression of IGFBP5 expression and inhibition of Wnt/β-catenin signaling. In vivo administration significantly reduced uterine fibrosis, glandular invasion, and inflammatory cytokine levels. These findings suggest that Ce-ZNC exerts immunomodulatory and anti-fibrotic effects in adenomyosis. While promising, further studies are required to elucidate biodistribution, long-term safety, and translational potential in human models.
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (24)
- Adenomyosis and Infertility-Review of Medical and Surgical Approaches via openalex
- Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015 via openalex
- Assessment of quality of sexual life in women with adenomyosis via openalex
- Developmental Toxicant Exposure Is Associated with Transgenerational Adenomyosis in a Murine Model via openalex
- Immunopathology and Therapeutic Perspectives of Endometriosis: Scientific Gaps and Emerging Advances in Translational Immunotherapy via openalex
- Impact of Adenomyosis on Infertile Patients-Therapy Options and Reproductive Outcomes via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Prevalence of adenomyosis in women undergoing surgery for endometriosis via openalex
- Proteomic detection of COX-2 pathway-related factors in patients with adenomyosis via openalex
- Unveiling the Pathogenesis of Adenomyosis through Animal Models via openalex
- β-catenin activates TGF-β-induced epithelial-mesenchymal transition in adenomyosis via openalex
- W4407792278 via openalex
- W4409602952 via openalex
- W4412706660 via openalex
- W2091430600 via openalex
- W2922267617 via openalex
- W4310448248 via openalex
- W4316669079 via openalex
- W4389099323 via openalex
- W4390226298 via openalex
- W4392886192 via openalex
- W4396743501 via openalex
- W4403039151 via openalex
- W4406664253 via openalex
Source provenance
- openalex
- last seen: 2026-10-06T06:07:52.081803+00:00
License: CC0
· commercial use OK